Advertisement
Advertisement

ACHV

ACHV logo

Achieve Life Sciences, Inc.

5.21
USD
Sponsored
+0.42
+8.77%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

5.23

+0.02
+0.46%

Achieve Life Sciences, Inc. Profile

About

Achieve Life Sciences Inc. is a pharmaceutical company. It develops and commercializes cytisine treatment to help people battling nicotine addiction. The Company's product candidates include Custirsen, Apatorsen and OGX-225. Achieve Life Sciences Inc., formerly known as OncoGenex Pharmaceuticals Inc., is based in Bothell, United States.

Info & Links

CEO

Richard Stewart

Headquarters

1040 West Georgia Street, Suite 1030
Vancouver, BC V6E 4H1, CANADA

Industry

Medical Drugs

Sector

Medical

Website

www.achievelifesciences.com

Auditor

PricewaterhouseCoopers LLP

Share holders

9

Employees

28

Achieve Life Sciences, Inc. Statistics

Valuation Measures

Market Capitalization2

537.32M

Enterprise Value

532.90M

Enterprise Value/EBITDA(ttm)

-9.76

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

8.21

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-204.14%

Return on Invested Capital(ttm)

-171.76%

Return on Assets(ttm)

-121.36%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-54.60M

Net Income Available to Common(ttm)

-54.65M

Diluted EPS(ttm)

-1.30

Share Statistics

Beta (5Y Monthly)

1.96

52-Week Change

114.40%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

53.24M

Dividend Yield

0.00%

Float4

51.64M

% Held by Insiders

3.00%

% Held by Institutions

33.52%

Balance Sheet

Total Cash(mrq)

36.40M

Total Cash Per Share(mrq)

0.68

Total Debt(mrq)

16.51M

Total Debt/Equity(mrq)

76.74%

Current Ratio(mrq)

4.39%

Quick Ratio(mrq)

4.39%

Book Value Per Share(mrq)

0.40

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.13

Free Cash Flow(ytd)

-49.47M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement